Cybin announces results of annual and special meeting of shareholders

Toronto--(business wire)--cybin inc. (nyse american:cybn) (neo:cybn) (“cybin” or the “company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is pleased to announce the voting results for each of the matters presented at the company's annual and special meeting of shareholders held on october 12, 2023 (the “meeting”). there were 66 shareholders represented in person or by proxy at.
CYBN Ratings Summary
CYBN Quant Ranking